Insider · CIK 0001401225
Baljinder Bhullar
Files at LEXX (Lexaria Bioscience Corp.). First filing -, latest -.
In brief
Baljinder Bhullar files SEC Form 4 as director at LEXX (Lexaria Bioscience Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Baljinder Bhullar has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 15, 2025 | LEXX Lexaria Bioscience Corp. | AGrant or award Stock Optionsderivative | +11,000 | $0.00 | $0 | 11,000 | May 16, 2025 |
Questions about Baljinder Bhullar
Answered from the filings on this page, as of the latest one.
Is Baljinder Bhullar buying or selling?
Baljinder Bhullar has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Baljinder Bhullar's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Baljinder Bhullar has 0.
Where does Baljinder Bhullar file Form 4?
Baljinder Bhullar has filed Form 4 at LEXX (Lexaria Bioscience Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.